T2 Biosystems announced results from the special meeting of stockholders on April 11…T2 Biosystems Stockholders voted for the approval of conversion of $15M of its term loan with entities affiliated with CRG Servicing into T2 Biosystems equity. “We appreciate our stockholders demonstrating their continued support for the Company by attending and voting at the special meeting earlier today. Following the debt conversion, we are expecting to strengthen our balance sheet by reducing both our total debt and quarterly interest payments to CRG by 36 percent. In addition, this decision signifies another step towards regaining compliance with the Nasdaq listing requirements that we continue to believe is in the best interest of both the Company and its stockholders,” said John Sperzel, Chairman and CEO at T2 Biosystems.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TTOO:
- T2 Biosystems Reinforces Market Position with Extended Vizient Agreement
- T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.
- T2 Biosystems announces extension of multi-year agreement with Vizient
- T2 Biosystems Anticipates Breakthroughs and Extends NASDAQ Compliance
- T2 Biosystems reiterates 2024 financial outlook
